Group One Trading’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$329 Hold
190
– – ﹤0.01% 7303
2026
Q2
$378 Buy
+190
New +$274 ﹤0.01% 7334
2026
Q1
– Sell
-86
Closed -$162 – 8064
2025
Q4
$206 Hold
86
– – ﹤0.01% 7885
2025
Q3
$245 Sell
86
-2,000
-96% -$6.85K ﹤0.01% 8205
2025
Q2
$7.86K Hold
2,086
– – ﹤0.01% 6865
2025
Q1
$9.45K Sell
2,086
-2,274
-52% -$12K ﹤0.01% 6295
2024
Q4
$30.8K Buy
4,360
+2,260
+108% +$18K ﹤0.01% 5414
2024
Q3
$17.1K Buy
2,100
+2,000
+2,000% +$14.5K ﹤0.01% 5317
2024
Q2
$639 Buy
+100
New +$642 ﹤0.01% 6426
2022
Q4
– Sell
-11,933
Closed -$115K – 7569
2022
Q3
$116K Buy
+11,933
New +$158K ﹤0.01% 4642
2020
Q2
– Sell
-538
Closed -$14.9K – 5932
2020
Q1
$14K Buy
+538
New +$16.4K ﹤0.01% 4420

Other funds holding HCAT

Group One Trading's HCAT Position: Q3 2026 in Review

Group One Trading held its Health Catalyst (HCAT) position steady in Q3 2026 at 190 shares worth $329. The position accounts for ﹤0.01% of the portfolio, ranked #7303.

Group One Trading first reported a position in HCAT in Q1 2020 and has held it in 11 quarters since. The position peaked at $116K in Q3 2022. 76 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.

  • Group One Trading held 190 shares of Health Catalyst worth $329 as of Q3 2026.
  • Group One Trading left its Health Catalyst share count unchanged in Q3 2026.
  • Health Catalyst made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7303 holding.
  • Group One Trading first reported a position in Health Catalyst in Q1 2020 and has held it in 11 quarters since.
  • Group One Trading's Health Catalyst position peaked at $116K in Q3 2022.
  • 76 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.